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Summary
The mechanisms regulating retinal ganglion cell (RGC) development are crucial for retinogenesis
and for the establishment of normal vision. However, these mechanisms are only vaguely understood.
RGCs are the first neuronal lineage to segregate from pluripotent progenitors in the developing retina.
As output neurons, RGCs display developmental features very distinct from those of the other retinal
cell types. To better understand RGC development, we have previously constructed a gene regulatory
network featuring a hierarchical cascade of transcription factors that ultimately controls the
expression of downstream effector genes. This has revealed the existence of a Pou domain
transcription factor, Pou4f2, that occupies a key node in the RGC gene regulatory network and that
is essential for RGC differentiation. However, little is known about the genes that connect upstream
regulatory genes, such as Pou4f2 with downstream effector genes responsible for RGC
differentiation. The purpose of this study was to characterize the retinal function of eomesodermin
(Eomes), a T-box transcription factor with previously unsuspected roles in retinogenesis. We show
that Eomes is expressed in developing RGCs and is a mediator of Pou4f2 function. Pou4f2 directly
regulates Eomes expression through a cis-regulatory element within a conserved retinal enhancer.
Deleting Eomes in the developing retina causes defects reminiscent of those in Pou4f2−/− retinas.
Moreover, myelin ensheathment in the optic nerves of Eomes−/− embryos is severely impaired,
suggesting that Eomes regulates this process. We conclude that Eomes is a crucial regulator
positioned immediately downstream of Pou4f2 and is required for RGC differentiation and optic
nerve development.
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Introduction
Among the six neuronal cell types in the vertebrate retina, retinal ganglion cells (RGCs) are
the sole output neurons conveying visual information into the brain. RGCs are also the first
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retinal cell type to differentiate. These features distinguish RGCs from the other retinal cell
types and emphasize the importance of elucidating the mechanisms that regulate RGC
development in order to create a comprehensive, integrated model of retinogenesis.
In the mouse, differentiating RGCs can first be visualized with molecular markers as early as
embryonic day 11.5 (E11.5) when dividing retinal progenitor cells (RPCs) cease mitosis and
migrate basally from the neuroblast side of the retinal epithelium towards the vitreal side to
the emerging ganglion cell layer (GCL) (Young, 1985a; Young, 1985b). We and others have
investigated the mechanisms controlling RGC fate specification and differentiation, and by
doing so, have identified key regulatory factors that are essential for these events to occur
normally (for reviews, see Mu and Klein, 2004; Mu and Klein, 2008; Cayouette et al., 2006).
In particular, we have proposed a gene regulatory network model for RGC development
featuring a hierarchical cascade of transcription factors that ultimately controls the expression
of terminal downstream effector genes (Mu et al., 2005). Two transcription factors occupy key
nodes in the RGC gene regulatory network: the proneural bHLH transcription factor Math5
(Atoh7 – Mouse Genome Informatics) and the class IV Pou domain-containing transcription
factor Pou4f2 (also called Brn3b). Math5 is responsible for endowing RPCs with the
competence to acquire a RGC fate (Brown et al., 2001; Wang et al., 2001), whereas Pou4f2 is
positioned genetically downstream of Math5 and is essential for RGC differentiation, cell
survival, neurite outgrowth and axon pathfinding (Erkman et al., 1996; Erkman et al., 2000;
Gan et al., 1996; Gan et al., 1999; Wang et al., 2000). Notably, RGCs that lack Pou4f2 are still
able to differentiate, albeit abnormally, and the expression of many RGC genes is refractory
to the absence of Pou4f2 (Mu et al., 2004). This suggests that pathways operate in parallel
along with Pou4f2 to control RGC differentiation (Mu et al., 2004; Mu et al., 2005).
For our RGC gene regulatory network model to be meaningful, connections must be made
between individual upstream regulatory genes such as Pou4f2 to terminal downstream genes
such as those that control axon projections. Unfortunately, with the exception of Pou4f1 (Trieu
et al., 1999), little is known about regulatory genes that might be direct targets of Pou4f2. We
therefore sought to determine whether any genes encoding transcription factors downstream
of Pou4f2 are direct Pou4f2 targets, and whether these transcription factors mediate the roles
played by Pou4f2 in regulating genes involved in terminal differentiation events. We focused
on the eomesodermin (Eomes) gene for the following reasons. Eomes (also referred to as
Tbr2) belongs to the Tbr1/Eomes/Tbet subfamily of genes (Naiche et al., 2005) that were
initially found to play essential roles during trophoblast and mesoderm development in mice
(Russ et al., 2000; Strumpf et al., 2005). Eomes is also expressed in the developing central
nervous system and has been implicated in the development of the human central nervous
system; a homozygous breakpoint mutation in a Moroccan family silences Eomes and leads to
microcephaly (Baala et al., 2007). Recent studies have also indicated that Eomes is a component
of a pathway that regulates glutamatergic neurogenesis in the cerebral cortex and cerebellum
in mouse development (Bulfone et al., 1999; Hevner et al., 2006; Quinn et al., 2007). Of
particular interest from the standpoint of our studies, Eomes was also found to be expressed in
the GCL of the retina (http://www.scripps.edu/cb/friedlander/gene_expression/), prompting us
to hypothesize that Eomes plays a role in RGC differentiation.
In this study, we extend the initial findings on Eomes in the developing retina by providing
evidence that Eomes is a direct target of Pou4f2, and by demonstrating a role for Eomes in
RGC differentiation and optic nerve development. We also discovered a novel role for
Eomes: that it regulates myelin ensheathment in the developing optic nerve.
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Materials and Methods
Generation of Eomesflox/flox mice and Eomes-enhancer transgenic embryos
A gene targeting vector was constructed containing a floxed Eomes allele in which exon 3 of
Eomes could be deleted by Cre-mediated recombination. We used genomic DNA from R1
embryonic stem (ES) cells to PCR amplify 1.63, 0.45 and 2.79 kb fragments from the Eomes
locus containing coding exons 1-5 and associated introns (see Fig. 6A). The amplified products
were sequentially subcloned into a targeting vector generated previously in our laboratory
(C.A.M., unpublished). The final targeting construct contained two loxP sites inserted into the
second and third introns and a PGK-neomycin cassette with flanking Frt sites inserted into
intron 3 adjacent to the loxP site (see Fig. 6A). The targeting construct was linearized and
electroporated into ES cells, after which G418-resistant ES cells were selected to identify
homologous recombination events. Targeted ES cell clones were identified by Southern
analysis (see Fig. 6B). Chimeric males were bred to wild-type C57/BL/6J females to generate
Eomes+/flox heterozygotes. To delete the Frt-neomycin cassette, we bred Eomes+/flox mice with
mice containing a Rosa26-FLPeR transgene (Farley et al., 2000). Eomesflox/flox homozygous
mice were obtained by interbreeding against the C57BL/6J background. Eomesflox/flox mice
were viable and fertile.
A CMV-Cre transgenic line was used to generate Eomes+/Δflox in one-cell zygotes (Su et al.,
2002). We then interbred Eomes+/Δflox mice to recover EomesΔflox/Δflox embryos, which
displayed phenotypes identical to those observed in germline-generated Eomes−/− embryos
(Russ et al., 2000). To delete exon 3 in the developing retina, Eomes+/flox mice were bred to
the Six3-Cre transgenic line, which expresses Cre in neural progenitor cells in the retina (Furuta
et al., 2000). The resulting Eomes+/flox;Six3-Cre males were bred to Eomesflox/flox females to
generate Eomesflox/flox;Six3-Cre embryos and neonates in which exon 3 was specifically
deleted in the retina (EomesΔflox/Δflox;Six3-Cre).
Three PCR primers were used simultaneously to distinguish wild-type, floxed and deleted
Eomes alleles (see Fig. 6C): Em15, 5′-CATGATTAAGGAAGGCTGGATGCAC-3′; Em16,
5′-AAGGAGACAGCCTTCACCCAGGC-3′; and Em18, 5′-
GACTGAGAAGTAAGAGGGTCAGCAG-3′. PCR primers used to genotype the Six3-Cre
transgene were Cre01, 5′-AACGAGTGATGAGGTTCGCAAGAAC-3′, and Cre02, 5′-
CGCTATTTTCCATGAGTGAACGAACC-3′.
To generate embryos carrying the Eomes-enhancer transgene, a 2.8 kb region from base pairs
−1182 to −3918 (translational start site, +1) of Eomes was subcloned into a plasmid containing
the hsp68-lacZ-pA reporter gene (Kothary et al., 1989). The Eomes-enhancer transgene was
used to generate transgenic embryos, which were collected at the desired times.
The US Public Health Service Policy on Humane Care and Use of Laboratory Animals was
followed in all experiments using mice, and the M. D. Anderson Institutional Animal Care and
Use Committee approved all animal protocols used in these experiments.
Histology studies, in situ hybridization, immunohistochemistry and X-gal staining
Embryos and eyes dissected from embryos or animals were fixed, paraffin-embedded and
sectioned into 7 μm or 12 μm slices for immunohistochemistry studies or in situ hybridization,
respectively (Mu et al.,2004). After de-waxing and rehydration, the sections were stained with
Hematoxylin and Eosin for histology studies. In situ hybridization was performed as described
by Mu et al. (Mu et al., 2004).
For the immunohistochemistry studies, sections were placed in a microwave oven at 600 watts
in 10 mM sodium citrate for 18 minutes to expose the antigen epitopes. Microwave-treated
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sections were then incubated with primary antibodies. A tyromide signal amplification kit
(TSA biotin system, PerkinElmer) was used in conjunction with a NovaRed kit (Vector Labs),
to detect Eomes protein expression by color, and the immunostained sections were
counterstained with Methyl Green. To detect Eomes expression using indirect
immunofluorescence, we used the TSA plus fluorescence kit to optimize the signal intensity.
For double-immunofluorescence labeling, Eomes expression was detected as described above
and the expression of all other proteins was detected using Alexa-conjugated secondary
antibodies (Invitrogen). The primary antibodies were anti-BrdU (Upstate, 1/4), anti-Brn3b/
Pou4f2 (Santa Cruz, 1/200), anti-GFP (Invitrogen, 1/1000), anti-NFL (Invitrogen, 1/250), anti-
syntaxin (Chemicon, 1/1000), anti-Tbr1 (Chemicon, 1/1000) and anti-Tbr2/Eomes (Chemicon,
1/1000). HRP-conjugated secondary antibody for tyromide signal amplification was obtained
from Jackson ImmunoResearch. Flat-mount retinas were prepared as described by Xiang et al.
(Xiang et al., 1995).
TUNEL assays and BrdU labeling
TUNEL assays on embryonic retinas were performed using an in situ cell death detection kit
(Roche Applied Science) following the manufacturer's instructions. Three paraffin-embedded
sections were used for data analysis. For pulse labeling with BrdU, 100 μg of BrdU (Upstate)
per gram of body weight was injected intraperitoneally into pregnant females 1 hour before
euthanization. Embryos were then processed as described previously by Fu et al. (Fu et al.,
2006).
Chromatin immunoprecipitation and electrophoretic mobility shift assays
E15.5 retinas were isolated for chromatin immunoprecipitation (ChIP) assays following the
procedures described by Wells and Farnham (Wells and Farnham, 2002) and Kiyama and Klein
(Kiyama and Klein, 2007). Two microliters of the immunoprecipitated chromatin DNA and
input genomic DNA were used for PCR amplification with the following primer sets: Eo3b007,
5′-GACCAACTTGCCACAAAAAACCC-3′ and Eo3b008, 5′-
CTGAACAGGCTTGCTGCATGCTC-3′; or TTN E4F, 5′-
TTGCAGCAACCACTCTTGTC-3′ and TTN E4R, 5′-GCATGATGGGAGAGGACCTA-3′.
PCR amplifications were performed for 30 cycles. The amplified products were resolved by
6% polyacrylamide gel electrophoresis and visualized by staining with GelStar nucleic acid
gel stain (CAMBREX).
Electrophoretic mobility shift assays (EMSAs) were performed as described by Mu et al. (Mu
et al., 2004). Oligonucleotides for the wild-type and mutated site A (see Fig. 4A) were: wild-
type, 5′-GGGAGTGCTGGTGACCCGTTAATGTTGGAATGTTTTCCTA-3′ and mutant, 5′-
GGGAGTGCTGGTGACCCGAAAAAGTTGGAATGTTTTCCTA-3′. Pou4f2 protein was
synthesized in vitro using a transcription/translation system (Promega), and 2 μl of the
transcription/translation reaction mixture was used for each EMSA reaction.
Cell cultures, DNA transfections, and lacZ reporter gene assays
U2OS cells were cultured in 10% Dulbecco's modified Eagle's medium and 10% fetal bovine
serum at 37°C in a 5% CO2 atmosphere. For the Eo2.8k (AmBm)-HSP68p-LacZ-pA plasmid,
the core Pou4f2 binding site A was changed from 5′-GTTAATGTT-3′ to 5′-GAAAAAGTT-3′
and site B was changed from 5′-ATTAATGAG-3′ to 5′-AAAAATGTG-3′ using the
Quikchange site-directed mutagenesis kit (Stratagene). Full-length Pou4f2 cDNA was
subcloned into pIRES-hrGFP-1a (Stratagene) for transactivation experiments. Transfections
were carried out on cover slides placed in six-well culture plates using FuGene HD (Roche)
following the manufacturer's instructions. Cells were co-transfected with 0.5 μg of the
Pou4f2 expression construct or the empty expression vector and 0.5 μg of the reporter plasmid.
X-gal staining was performed 36 hours after transfection. Transfection efficiency was
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determined by visually inspecting the number of GFP-expressing cells for each experiment.
All experiments were performed in triplicate.
Results
Spatiotemporal pattern of Eomes expression in the developing retina
We determined the spatial and temporal pattern of Eomes transcripts in the retina at E14.5 and
E16.5 using sectioned in situ hybridization. At E14.5, the first signs of Eomes expression in
the retina were mainly in the GCL, although cells within the neuroblast layer (NBL) were
sparely labeled (Fig. 1A). At E16.5, Eomes continued to be expressed in the GCL and NBL
(Fig. 1B). We also found Eomes to be strongly expressed in the forebrain, a previously known
site of Eomes expression (Bulfone et al., 1999) (Fig. 1B). To determine whether Eomes is
expressed at stages earlier than E14.5, we performed immunohistochemistry with anti-Eomes
antibody in sections obtained at E13.5. Although Eomes protein was readily detected in the
forebrain at this stage, it was not detected in the retina (Fig. 1C).
Because the GCL consists of displaced amacrine cells as well as RGCs, it was possible that
Eomes was expressed in either both or one of these neuronal cells types. To test these
possibilities, we performed immunohistochemistry in sections of wild-type and Math5−/−
retinas obtained at E16.5. Retinas of Math5−/− embryos lack RGCs and in their place are
increased numbers of displaced amacrine cells (Wang et al., 2001). Although wild-type retinas
strongly expressed Eomes in the GCL, Eomes expression in Math5−/− retinas was virtually
undetectable (Fig. 1D,E). These results demonstrated that RGCs in the GCL are the major site
of Eomes expression from E14.5 to E16.5, a time when newly forming RGCs are populating
the GCL.
Pou4f2 is one of the earliest markers of RGC differentiation (Gan et al., 1999) and is expressed
in newly forming RGCs within the NBL and in differentiated RGCs that have migrated to the
GCL (Gan et al., 1999). By comparing Pou4f2 and Eomes protein expression, we determined
how much the expression of the two transcription factors overlapped and their potential
relationship to each other. Although Eomes expression was not detected in retinas at E13.5
(Fig. 1C), Pou4f2 was already expressed at high levels at this time (Gan et al., 1999). By E14.5,
Eomes expression was apparent and coincided with the existence of a subset of Pou4f2-
expressing cells within the GCL (Fig. 1F-H). However, many Pou4f2-expressing cells,
particularly those still migrating to the GCL, did not express Eomes. In addition, although
Pou4f2 was expressed in RGCs throughout the GCL, Eomes was not expressed in the
peripheral-most region (Fig. 1H). This would be in keeping with the fact that neuronal
differentiation begins at the center and advances to the periphery of the retina. At E16.5,
expression of Pou4f2 was largely confined to the GCL and many, but not all, of the Pou4f2-
expressing cells also expressed Eomes (Fig. 1I-K). These results suggested that RGCs
increasingly express Eomes as they migrate to the GCL and undergo terminal differentiation.
Weaker expression of Eomes within the NBL at E14.5 and E16.5 did not overlap with the
expression of Pou4f2 and persisted throughout retinogenesis. As cells within the NBL are a
mixture of mitotically active RPCs and newly formed postmitotic cells that have left the cell
cycle and committed to a retinal cell fate (Le et al., 2006), we determined whether Eomes was
expressed in mitotic cells by pulse-labeling S-phase cells of the E18.0 retinas with BrdU and
comparing the relative distributions of the S-phase cells and Eomes-expressing cells. We
detected little, if any, overlap between these two cell populations (Fig. 2A-C), suggesting that
Eomes-expressing cells are mainly postmitotic.
We also observed that retinal Eomes expression persisted into postnatal life. In particular,
Eomes was observed to be strongly expressed in the GCL and in the innermost region of the
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emerging inner nuclear layer (INL) of newborn mice (P0) (Fig. 2D). Weaker expression was
observed throughout the NBL (Fig. 2D). However, Eomes expression was largely absent in
the GCL but persisted in the INL and NBL of retinas of newly born Math5−/− mice (Fig. 2E).
Because amacrine cells are the major cell type in the innermost region of the INL, it is possible
that the Eomes-expressing cells were amacrine cells and that the Eomes-expressing cells in the
NBL were amacrine cell progenitors.
At P12, Eomes expression was detected in a subpopulation of cells in the GCL, where its
expression co-localized with that of the RGC marker neurofilament light subunit (NFL) (Fig.
2F). At P30, Eomes expression in the INL co-localized with that of the pan-amacrine cell
marker syntaxin (Fig. 2G) but not of other amacrine cell markers calbindin and parvalbumin
(data not shown). A few Eomes-expressing cells in the INL were found to be colocalized with
the amacrine marker calretinin (data not shown). These results suggested that Eomes-
expressing cells in the INL constituted a distinct subpopulation of amacrine cells.
Identification of a phylogenetically conserved Eomes retinal enhancer
Because Pou4f2 is expressed in newly arising RGCs and is required for RGC differentiation,
Eomes might be positioned genetically downstream of Pou4f2, making it a potential target gene
of Pou4f2. If this were the case, Eomes expression would necessarily depend on the presence
of functional Pou4f2. To test this possibility, we determined the level of Eomes protein
expression in retinas isolated from Pou4f2+/− (wild type) and Pou4f2−/− embryos. We
performed the analysis at E14.5 because Pou4f2−/− retinas have the same number of RGCs as
wild-type retinas at that stage. Eomes expression in the GCL strictly depended on Pou4f2;
Eomes protein in the GCL was undetectable in Pou4f2−/− retinas but clearly detectable in
Pou4f2+/− control littermates (Fig. 3A,B).
These results indicated that Eomes is genetically downstream of Pou4f2 but they did not show
whether Pou4f2 is directly involved in regulating Eomes transcription. We therefore
determined whether conserved noncoding sequences containing Pou4f2 consensus DNA-
binding sites [5′-(A/G)TTAATGAG(C/T)-3′; Xiang et al. (Xiang et al., 1995)] could be
identified within the Eomes locus. We focused our search on a 20 kb stretch of genomic DNA
that encompasses the Eomes gene along with 9.5 kb of DNA upstream of the Eomes
translational initiation codon and 4.1 kb of DNA downstream of the Eomes translational
termination codon. By comparing human, mouse, rat and dog genomes, we identified several
blocks of conserved noncoding sequences that were located within the upstream and
downstream DNA sequences flanking Eomes (Fig. 3C). Furthermore, two putative Pou4f2-
binding sites were identified in two closely separated regions. One site (site B, Fig. 3C,D)
began at base pair −2937 (5′-ATTAATGAG-3′) and its sequence precisely matched that of the
consensus Pou4f2-binding site. The other site (site A, Fig. 3C,D) began at base pair −3854 (5′-
GTTAATGTT-3′) and differed from another Pou4f2-binding site by one base pair. However,
Pou4f2-binding site B was not conserved in the corresponding position in human, rat and dog
genomes (Fig. 3D). By contrast, Pou4f2-binding site A was located within a highly conserved
192 bp region (Fig. 3D), and this site was present in all four vertebrate genomes with the
exception of one mismatched nucleotide in the dog genome.
To determine whether the conserved upstream regions containing the Pou4f2-binding sites
were capable of directing expression in the developing retina, we constructed a transgene
containing a 2.8 kb fragment that included both Pou4f2-binding sites fused to an hsp68-
promoter-lacZ-pA reporter gene (Fig. 3E). The resultant transgenic E14.5 embryos expressed
lacZ in retinas and limbs, a previously known region of Eomes expression (Russ et al., 2000)
(Fig. 3E). In control experiments, a transgene construct with disabling mutations in sites A and
B did not express in either the limb or retina (data not shown). In the wild-type construct,
lacZ was expressed in a narrow strip within the inner part of the retina just above the GCL
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(Fig. 3F). β-Galactosidase-stained retinal sections co-stained with anti-Eomes antibody,
showed that most of the lacZ-expressing cells did not co-express the endogenous Eomes protein
(compare Fig. 3A with 3F). A possible explanation for the lack of overlap is that the lacZ-
expressing cells represent newly forming RGCs in the process of migrating to the GCL. To
determine whether this was the case, we performed immunohistochemistry analysis of β-
galactosidase-stained retinal sections from E14.5 transgenic embryos using anti-Brn3b
(Pou4f2) antibody. From these experiments, it was clear that most of the lacZ-expressing cells
also expressed Pou4f2, although Pou4f2 expression was present in many cells that were not
expressing the transgene (Fig. 3G). These results demonstrated that the 2.8 kb fragment is
sufficient to direct transgene expression in a subpopulation of RGCs and that this subpopulation
also expresses Pou4f2. However, the transgene appeared to be expressed at earlier stages in
RGC differentiation than the stages when endogenous Eomes is expressed. The reason why
transgene and Eomes expression do not correlate is uncertain, but it suggests that crucial cis-
regulatory elements are missing in the 2.8 kb region. Consistent with this, a 225 kb Bac
transgenic mouse line containing Eomes fused to an eGFP reporter (Bac Eomes∷GFP) (Kwon
and Hadjantonakis, 2007) expresses GFP in the GCL of E14.5 and E16.5 retinas in a manner
similar to that of endogenous Eomes expression (Fig. 3H-K).
To determine whether either Pou4f2-binding sites A or B within the 2.8 kb fragment bind to
Pou4f2, we used EMSA to detect Pou4f2 binding in vitro and ChIP to detect Pou4f2 binding
in vivo. EMSA was performed using an in vitro-synthesized full-length Pou4f2 protein and an
oligonucleotide probe containing the putative Pou4f2-binding site A within the conserved 192
bp region. We detected a specific Pou4f2-DNA complex but no complex was formed with
transcription-translation lysates that lacked the Pou4f2 template (Fig. 4A). The formation of
the Pou4f2-DNA complex was inhibited when excess homologous unlabeled oligonucleotide
competitor but not when excess oligonucleotide competitor containing a mutated Pou4f2 site
was added. Addition of the anti- Pou4f2/Brn3b antibody also blocked complex formation (Fig.
4A). Notably, an oligonucleotide competitor containing the Pou4f2-binding site B did not
interfere with complex formation, suggesting that this nonconserved sequence was not a bona
fide Pou4f2-binding site.
ChIP analysis was performed using chromatin prepared from E15.5 retinas and primer pairs
that would reveal Pou4f2 bound to the Pou4f2-binding site within the conserved 192 bp region.
This showed that a 122 bp fragment was amplified after immunoprecipitation with anti-Brn3b
antibody (Fig. 4B), but not with preimmune IgG, which served as a negative control (data not
shown). In addition, sequences derived from the gene encoding the muscle-specific protein
Titin were not immunoprecipitated with anti-Brn3b antibody (Fig. 4B). We also performed
ChIP experiments using anti-acetylated-histone H3 antibody to determine whether the Pou4f2-
binding site was within a region of open (acetylated) chromatin, a finding that would indicate
active expression. The 122 bp fragment was also amplified after immunoprecipitation with
anti-acetylated-histone H3 antibody, whereas sequences from the gene encoding Titin were
not (Fig. 4B). Both the Pou4f2-binding site and Titin sequences were amplified after
immunoprecipitation with anti-histone H3 antibody, which ubiquitously marks the presence
of nucleosomes (Fig. 4B). These results implicate Pou4f2 as a direct transcription regulator of
Eomes expression acting at the Pou4f2-biding site A within the conserved 192 bp region. A
similar ChIP analysis was performed using the nonconserved Pou4f2-binding site B. A very
weak PCR product was observed when primer pairs were used that amplified a 157 bp fragment
containing the putative Pou4f2 site B (data not shown). This result was consistent with the
view that the nonconserved Pou4f2 site B is likely to have only a minor function, if any, in
vivo.
To provide further evidence that Pou4f2 is a transcriptional regulator of Eomes, we performed
transient transactivation assays in U2OS cells using the 2.8 kb fragment-lacZ reporter gene
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construct containing Pou4f2-binding sites A and B (see Fig. 3E). A control construct, Eo2.8K
(AmBm)-HSP68p-LacZ-pA, was generated in which binding sites A and B were mutated. The
number of cells expressing lacZ was sharply increased when the wild-type construct was co-
transfected with the Pou4f2 expression plasmid (Fig. 5A,B), with little increase in the number
of cells with the mutated construct (Fig. 5C,D). These results demonstrate that Pou4f2 is able
to activate transcription from the 2.8 kb fragment and suggest that Pou4f2-binding to site A,
and to a lesser extent site B, enhances Eomes transcription in RGCs.
Abnormal RGC and optic nerve development in EomesΔflox/Δflox retinas
To assess the role of Eomes in the developing retina, we generated mice with a floxed allele
of Eomes and bred them with a Six3-Cre transgenic mouse line to delete exon 3 of Eomes in
the developing retina (Fig. 6). Histological retinal sections of EomesΔflox/Δflox mice at P24
showed a slight reduction in the thickness of the GCL compared with Eomes+/flox controls,
whereas the INL and ONL were normal (Fig. 7A,B). This suggests that in the absence of
Eomes, the RGCs are reduced in number and that they possess other defects as well.
To visualize the RGC axons, we prepared flat mounts of retinas that were
immunohistochemically stained with anti-NFL antibody. In EomesΔflox/Δflox P30 retinas, we
observed ∼30% reduction in the number of RGC axons in both the central and peripheral
regions of the retina when compared with Eomes+/flox retinas (Fig. 7C-F). The density of the
axon bundles was also notably reduced, and their orientation towards the optic disk appeared
abnormal (arrowheads, Fig. 7F). The reduction in the number of RGCs and the defects
associated with RGC axons associated with EomesΔflox/Δflox retinas were similar to those
identified in Pou4f2−/− retinas, although the overall effects appeared less severe in
EomesΔflox/Δflox retinas.
As RGCs undergo enhanced apoptosis between E15.5 and E18.5 in Pou4f2−/− retinas (Gan et
al., 1999), we performed a TUNEL analysis of sectioned retinas from Eomes+/flox and
EomesΔflox/Δflox embryos and postnatal mice to look for differences in apoptosis patterns
between the two. Although there was no significant enhancement of apoptosis through E16.5
(data not shown), at E18.5 we detected a dramatic increase in apoptotic cells in
EomesΔflox/Δflox retinas in both the GCL and NBL with respect to Eomes+/flox retinas
(arrowheads, Fig. 7G-J). At P1, P6 and P12, the number of apoptotic cells was consistently
higher in EomesΔflox/Δflox retinas than in Eomes+/flox controls, but the differences were less
dramatic than they were at E18. (Fig. 7I,J). Apoptotic cells were also observed in the GCL,
INL and ONL. We did not observe significant differences between EomesΔflox/Δflox retinas and
Eomes+/flox controls after P12. These results suggest that the reduced number of RGCs that we
observed in the retinas of P30 EomesΔflox/Δflox mice resulted from the enhanced apoptosis of
RGCs within the GCL between E18 and P12. However, the reason for increased cell death in
the retinal NBL, INL and ONL of embryos and postnatal EomesΔflox/Δflox mice is uncertain.
Some of the apoptotic cells might represent the Eomes-positive amacrine cells and their
progenitors that weakly expressed Eomes in the NBL at earlier stages.
As the expression of Eomes in RGCs correlated with the time when RGC axons reach the optic
chiasm, this raised the possibility that Eomes might play a role in regulating some aspects of
RGC axon formation. To assess this possibility, we isolated optic nerves from adult
EomesΔflox/Δflox and Eomes+/flox mice, and examined their ultrastructure (Wang et al., 2000).
In a section about 0.5 cm from the optic disk, a region where mature RGC axons are well
myelinated and ensheathed, low-magnification TEM showed that the area of EomesΔflox/Δflox
optic nerves was 30% smaller than that of Eomes+/flox optic nerves (Fig. 8A,B), consistent with
the finding that RGC numbers were reduced by ∼30%. At higher magnifications, we observed
striking differences between EomesΔflox/Δflox and Eomes+/flox optic nerves (Fig. 8C,D). In
particular, the axons in the optic nerves of Eomes+/flox mice were ensheathed with a well-
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organized, compact myelinated layer. However, only a few axons in the optic nerves of
EomesΔflox/Δflox mice were myelinated and where present, myelin ensheathment was thinner,
disorganized and loosely packed (Fig. 8C, parts iii-vi, Fig. 8D, parts iii-vi). Moreover, in the
optic nerves of EomesΔflox/Δflox mice, we observed neurites that were smaller in diameter than
those of normal axons and that contained large numbers of microtubules rather than the
neurofilaments normally associated with RGC axons in the optic nerve (arrowheads, Fig. 8D,
part vi). This finding was highly reminiscent of the abnormalities we observed in the optic
nerves of Pou4f2−/− mice reported earlier (Wang et al., 2000). Because we had not in that study
determined whether myelination was abnormal in Pou4f2−/− optic nerves, we performed a
similar TEM analysis in Pou4f2−/− mice. We found, indeed, that there were similar defects in
myelination and ensheathment in Pou4f2−/− mice (data not shown), providing additional
evidence that Eomes mediates the functions of Pou4f2 in RGC and optic nerve development.
Discussion
In this study, we found that Eomes is expressed in differentiated RGCs within the GCL but not
in committed progenitors or newly forming RGCs within the NBL. We further observed that
Eomes expression begins when Pou4f2 expression is maximal and depends on Pou4f2. Our
results therefore provide evidence that Eomes is a direct target gene of Pou4f2. We also found
that a 2.8 kb fragment upstream of Eomes, which encompasses a highly conserved 192 bp
region that contains a Pou4f2-binding site, directs RGC expression in transgenic embryos.
Furthermore, Pou4f2 binds efficiently to and activates transcription from this site. Analysis of
EomesΔflox/Δflox retinas indicated that Eomes plays roles similar to but more restricted than that
of Pou4f2 in RGC differentiation, cell survival and optic nerve development. Overall, our
results argue strongly for our hypothesis that Eomes is positioned immediately downstream of
Pou4f2 and is a mediator, at least in part, of Pou4f2 function. Eomes, therefore, appears to be
an important transcription factor that connects Pou4f2 to the expression of genes associated
with terminal differentiation, particularly those involved in axon outgrowth and optic nerve
development.
Eomes as a likely target gene of Pou4f2
When fused to a minimal promoter and a lacZ reporter transgene, a 2.8 kb fragment upstream
of Eomes that contains several conserved noncoding sequence blocks directs reporter gene
expression to a subpopulation of cells within the NBL that co-express Pou4f2. The fact that
the cells expressing the transgene are in the NBL and that they also express Pou4f2 strongly
suggests that the cells are newly forming RGCs in the process of migrating from the NBL to
the GCL. As transgene expression in the retina is highly restricted to these Pou4f2-expressing
cells, this implies that Eomes expression is dependent on the presence of Pou4f2. However,
endogenously expressed Eomes is clearly found in RGCs that also express Pou4f2 but have
already migrated to the GCL. Thus, the 2.8 kb fragment does not faithfully reproduce the
endogenous expression pattern of Eomes. Nevertheless, retinal expression of the transgene is
highly restricted to RGCs. A possible explanation for this is that additional cis-regulatory
elements lying outside the 2.8 kb fragment modulate the spatiotemporal activity of Eomes.
Indeed, a 225 kb Bac Eomes-eGFP transgene appears to recapitulate endogenous Eomes
expression, suggesting that Eomes is regulated by multiple enhancer inputs, one of which is
within the 2.8 kb region. In addition, non-deleted Eomes transcripts are downregulated in
EomesΔflox/Δflox retinas, suggesting that Eomes regulates its own expression (C.-A.M. and
W.H.K., unpublished).
Eomes in RGC differentiation and retinal development
Major defects were observed in the retinas of EomesΔflox/Δflox mice. This included reduced
numbers of RGC, abnormal RGC axon outgrowth and an aberrant and disorganized myelin
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sheath surrounding RGC axons. The massive cell death in the GCL associated with the loss of
Eomes indicates that Eomes is required for the survival of at least some RGCs. Presumably,
the absence of Eomes results in abnormal differentiation, which in turn triggers apoptosis. The
increased number of apoptotic cells in other retinal layers might be associated with the weak
expression of Eomes observed in non-RGCs or might be an indirect consequence of abnormal
levels of apoptotic cells within the GCL.
One of the striking retinal defects in EomesΔflox/Δflox embryos is the disorganized and loosely
packed myelin sheaths surrounding RGC axons in the optic nerve. Axon ensheathment is
essential for the normal propagation of membrane potential, and when defective, results in
slow and continuous depolarization along the axon (Waxman et al., 1995). It is therefore likely
that the propagation of visual signals into the brain is severely compromised in
EomesΔflox/Δflox mice. Because axon outgrowth and myelination require changes in the cell
adhesion properties of axons (Bartsch, 2003), the abnormal ensheathment possibly has its
source in defective cell adhesion. Many members of the T-box transcription factor family,
including Eomes, are involved in regulating genes whose products are important for cell
adhesion (Strumpf et al., 2005; Inman and Downs, 2006). Eomes acting downstream of Pou4f2
might therefore regulate the genes whose products are required for substrate adhesion.
T-box proteins in retinal development
Several members of the T-box transcription factor family besides Eomes are also expressed in
retinal development. The vertebrate orthologs of the Drosophila gene optomotor-blind, Tbx2,
Tbx3 and Tbx5, are expressed early in the dorsal part of the developing retina and are thought
to function in dorsoventral axial patterning (Pflugfelder et al., 1992; Sowden et al., 2001). In
addition, Tbx12 and Tbx20 are expressed in the developing retina and Tbx12 is required for
the formation of retinal cells and the organization of retinal layers (Carson et al., 2000; Carson
et al., 2004; Kraus et al., 2001).
A conserved DNA-binding T-domain is found in all T-box transcription factors (Kispert and
Herrmann, 1993; Bruneau et al., 2001; Conlon et al., 2001; Paxton et al., 2002; Wang et al.,
2004) and a consensus T-box element is believed to be the binding site for all members of the
T-box transcription factor family. Thus, it is possible that other T-box factors partially
compensate for the loss of Eomes. To examine whether the absence of Eomes resulted in an
upregulation of other T-box genes, which would be indicative of compensation, we determined
the expression patterns of eight T-box genes in Eomes+/flox and EomesΔflox/Δflox retinas. We
were able to detect retinal expression of only Trb1 and Tbx5, and no significant differences in
expression were observed between Eomes+/flox and EomesΔflox/Δflox retinas (see Fig. S1 in the
supplementary material). It therefore seems likely that Eomes has evolved a specialized
function in RGC development and is positioned in the RGC gene regulatory hierarchy
downstream of Math5 and Pou4f2.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Eomes expression in the developing retina
Retinal sections from the indicated developmental stages were labeled with an Eomes antisense
probe (A,B) or anti-Eomes antibody (C-K). Eomes expression starts at E14.5 in the innermost
layer of developing retina (A). At E16.5, Eomes expression is mainly localized in the same
area (B, black arrowhead) and in the forebrain (white arrowhead). At E13.5, although Eomes
expression is detected in the developing forebrain (C, arrowhead), it is undetectable in the
retina. (D,E) In Math5+/− retinas (D), Eomes is detected in the GCL (strongly) and NBL
(weakly), but in Math5−/− retinas (E), Eomes expression in GCL is undetectable. (F-H) At
E14.5, Pou4f2 and Eomes colocalize in RGCs in the innermost layer. Developing RGCs in the
NBL with strong Pou4f2 expression are Eomes negative. Weak Eomes expression can be
detected in the NBL at E14.5. (I-K) At E16.5, expression of Pou4f2 and Eomes is largely
restricted to the GCL. Scale bars: 500 μm in C; 200 μm in D,E; in H, 100 μm for F-H; in K,
50 μm for I-K.
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Fig. 2. Eomes expression in the NBL
(A-C) An E18 retina pulse-labeled with BrdU: anti-Eomes (A), anti-BrdU (B) and merged
image (C). (D) At P0 in Math5+/− retinas, Eomes is expressed in the GCL and NBL. (E) At P0
in Math5−/− retinas, much of the Eomes expression is absent from the GCL but not the NBL.
(F) At P12, some Eomes-positive cells in the GCL co-localize with NFL (arrowheads). Eomes
is expressed in the nucleus and NFL is expressed in the cytoplasm. (G) At P30, Eomes is
expressed in the GCL and in a subset of amacrine cells that are co-labeled with syntaxin
(arrowheads). Syntaxin expression is cytoplasmic. The boxed region in the inset is enlarged to
emphasize the co-localization of nuclear Eomes and cytoplasmic syntaxin expression. Scale
bars: in C, 100 μm for A-C; in E, 100 μm for D,E; 10 μm in insets in F,G.
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Fig. 3. Identification of an upstream Eomes retinal enhancer containing Pou4f2-binding sites
(A,B) E14.5 retinal sections from Pou4f2+/lacZ and Pou4f4lacZ/lacZ embryos immunostained
with anti-Eomes antibody and counterstained with propidium iodide. (C) 20 kb Vista analysis
of Eomes comparing mouse, human, dog and rat genomes. Pou4f2-binding sites A and B are
indicated by arrowheads. (D) The DNA sequence of Pou4f2 sites A and B. The 2.8 kb retinal
enhancer fragment is indicated in red. (E) Transgenic embryos carrying Eo2.8k-HSP68p-
LacZ-pA construct stain positively in the retina and limb (arrowheads). (F) Histological retinal
section of Eo2.8k-HSP68p-LacZ-pA E14.5 embryos shows lacZ expression in RGCs within
the NBL. lacZ-expressing cells co-localized with Pou4f2-expressing cells, detected using anti-
Pou4f2 antibody (G). (H-K) GFP expression in Bac Eomes∷GFP retinas. GFP fluorescence in
retinas from E14.5 (H) and E16.5 (J) embryos. There is intense auto-fluorescence in retina
pigment epithelia layer (RPE). Immunostaining using Alexa-555-anti-GFP antibody on retinal
sections from E14.5 (I) and E16.5 (K) embryos. Scale bars: 100 μm in B,G,K for A,B, F,G and
H-K, respectively.
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Fig. 4. EMSA and ChIP of Pou4f2-binding to site A within the Eomes retinal enhancer
(A) Pou4f2 binds to site A in vitro. A probe containing Pou4f2-binding site A forms a Pou4f2-
DNA complex. The left-most lane shows the free probe (F.P.). The second lane shows the
Pou4f2-DNA complex formed in the presence of in vitro-synthesized Pou4f2. Free probe and
complex are indicated by arrows. The remaining lanes show the extent of complex formation
in the presence of a 500-fold molar excess of wild-type (WT) and mutated (MT) site A
oligonucleotides, site B oligonucleotide, and anti- Pou4f2 antibody. (B) ChIP analysis using
retinas from E15.5 embryos shows occupancy of Pou4f2 at site A. Sequences around Eomes
site A or Titin were amplified after immunoprecipitation with anti-Pou4f2/Brn3b, anti-
acetylated-histone H3 or anti-histone H3 antibodies. The left lanes show the expected size of
the amplified products generated using input chromatin extracts. The right lanes show the
amplified products resulting from the immunoprecipitation of chromatin extracts. The middle
lanes show the amplified products generated using mock immunoprecipitation of chromatin
extracts without the primary antibody.
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Fig. 5. Transcriptional activity of the upstream Eomes retinal enhancer
U2OS cells were transfected using Eo2.8k-HSP68p-LacZ-pA (A,B) or Eo2.8k (AmBm)-
HSP68p-LacZ-pA plasmid (C,D) without (A,C) or with (B,D) CMV-Pou4f2 plasmid. Scale
bar: 200 μm.
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Fig. 6. Generation of a floxed conditional Eomes allele and creation of Eomesflox/flox mice
(A) Genomic structure of Eomes, the targeting construct, the targeted Eomes allele
(Eomesflox) and the deleted allele (EomesΔflox). Exons are designated as E1-E6. The black and
gray bars indicate the regions that were amplified from genomic DNA to generate the targeting
construct. Small arrows below the constructs represent the primers used for PCR genotyping.
Red boxes indicate loxP sites, and green bars indicate FRT sites. (B) Southern blot analysis of
DNA isolated from ES cells. The 5′ probe recognizes 15 kb wild-type and 11.2 kb targeted
EcoRV fragments. A targeted ES cell is shown in the middle lane, whereas the left and right
lanes are untargeted ES cells. (C) Representative PCR genotyping from tail DNA using a three-
primer PCR strategy for the different Eomes alleles and Cre transgene. The top gel represents
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Eomes allele genotyping, and the bottom gel shows the presence of the Cre transgene. In the
top gel, the arrows from top to bottom indicate products amplified from primers 15/18 (303
bp for Δflox), 15/16 (222 bp for flox) and 15/16 (166 bp for wild-type), respectively. The 303
bp fragment for the Δflox allele was often preferentially amplified (lanes 1, 2, 3, 5 and 9) from
the tail DNA because of leaky expression from the Six3-Cre transgene.
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Fig. 7. Reduced numbers of RGCs and RGC axons and cell death in EomesΔflox/Δflox mice
(A,B) Retinal sections from Eomes+/flox (A) and EomesΔflox/Δflox (B) retinas at P24 were stained
with Hematoxylin and Eosin. (C-F) Immunostaining using anti-NFL antibody on flat-mount
Eomes+/flox (C,E) and EomesΔflox/Δflox (D,F) retinas. NFL staining in the central region of the
EomesΔflox/Δflox retina is less intense and sparser than in the Eomes+/flox control retina (C,D).
The difference is more noticeable in the peripheral region (E,F). Many axons are oriented
aberrantly (F, arrowheads). OD, optical disc. (G,H) Representative cell death pattern at E18.
In EomesΔflox/Δflox retinas (H), massive cell death can be detected while Eomes+/flox control
retinas show little cell death (G). (I,J) Cell death profile from E18 to P24 in the GCL (I), and
in the INL and ONL (J).
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Fig. 8. Defects in optic nerve development and myelin ensheathment in EomesΔflox/Δflox mice
(A,B) Low-magnification images of cross-sections of optic nerves from Eomes+/flox (A) or
EomesΔflox/Δflox (B) P30 mice. Arrowheads indicate the size of the optic nerve. (C,D) Higher
magnification images of cross-sections of optic nerves from Eomes+/flox (C) and
EomesΔflox/Δflox (D) P30 mice. Arrowheads in D, part vi point to abnormal neurites. Each row
in C and D represents a higher magnification. Scale bars: 2 μm in C,D, parts i.
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